Rephonic
Artwork for JCO Precision Oncology Conversations

JCO Precision Oncology Conversations

American Society of Clinical Oncology (ASCO)
Circulating Tumor DNA
Clinical Trials
Immunotherapy
Prostate Cancer
Precision Oncology
Lung Cancer
Liquid Biopsy
Lynch Syndrome
Pancreatic Cancer
Colorectal Cancer
Breast Cancer
Lungmap
Oncology
Renal Cell Carcinoma
Small Cell Lung Cancer
Gastric Cancer
Biomarkers
Non-Small Cell Lung Cancer
Prostate Cancer Genetic Testing
Cancer Screening

JCO Precision Oncology Conversations podcasts features discussions with leading authors of JCO Precision Oncology articles, hosted by Dr. Abdul Rafeh Naqash. Join our experts in engaging conversations as they examine groundbreaking research in the world of precision oncology and learn how these advancements are redefining treatment protocols. The year's fellows summarize the top JCO Precision Onco... more

PublishesTwice monthlyEpisodes68Founded4 years ago
Number of ListenersCategories
MedicineHealth & Fitness

Listen to this Podcast

Artwork for JCO Precision Oncology Conversations

Latest Episodes

In this JCO PO Article Insights episode, host Carolyn Lineen summarizes the article, "Prognostic Significance of Blood-Based Multicancer Detection in Circulating Tumor DNA: Five-Year Outcomes Analysis" bySwanton et al.

LINK TO FULL TRANSCRIPT

YouTube

In this JCO PO Article Insights episode, host Jordan Goldstein summarizes the article, "Generic Protocols for Analytical Validation of Tumor-Informed Circulating Tumor DNA Assays for Molecular Residual Disease: The Blood Profiling Atlas in Cancer's M... more

In this JCO Precision Oncology Article Insights episode, host Dr. Carolyn Lineen summaries the article, "Concordance of Oncotype DX Breast Recurrence Score Assay Results Between Paired Core Needle Biopsy and Surgical Excision Specimens in Hormone Rec... more

YouTube

JCO PO author Dr. Foldi at UPMC Hillman Cancer Center and University of Pittsburgh School of Medicine shares insights into the JCO PO article, "Personalized Circulating Tumor DNA Testing for Detection of Progression and Treatment Response Monitoring ... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

ASCO Daily News
ASCO Daily NewsAmerican Society of Clinical Oncology (ASCO)
Journal of Clinical Oncology (JCO) Podcast
Journal of Clinical Oncology (JCO) PodcastAmerican Society of Clinical Oncology (ASCO)
ASCO Guidelines
ASCO GuidelinesAmerican Society of Clinical Oncology (ASCO)
Science Friday
Science FridayScience Friday and WNYC Studios
OncLive® On Air
OncLive® On AirOncLive® On Air

Recent Guests

Dr. Aziza Nassar
Author of the discussed article on Oncotype DX Breast Recurrence Score Assay
Episode: Oncotype DX Breast Recurrence Score® Results from Paired CNB & SE Specimens
Dr. Julia Foldi
Assistant professor of medicine in the Division of Hematology-Oncology at the University of Pittsburgh School of Medicine and the Magee-Womens Hospital of the UPMC.
University of Pittsburgh
Episode: ctDNA in Metastatic Invasive Lobular Carcinoma
Dr. Rebecca Hassoun
Researcher and author of the discussed article and expert in oncology
Episode: JCO PO Article Insights: Circulating Tumor DNA in Germ Cell Tumors
Dr. Zao Wainberg
Professor of Medicine at UCLA and Co-Director of the UCLA GI Oncology Program
UCLA
Episode: FGFR2b Prevalence in Advanced GC: FORTITUDE-101 Prescreening
Dr. Shilpa Gupta
Director of Genetic Urinary Medical Oncology at the Cancer Institute and Co-leader of GU Oncology Program at the Cleveland Clinic
Cleveland Clinic
Episode: FGFR3 Alteration Status and Immunotherapy in Urothelial Cancer
Dr. Jessica Ross
Third year medical oncology fellow at the Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Episode: DLL3 and SEZ6 Expression in Neuroendocrine Carcinomas
Dr. Alissa Cooper
Thoracic medical oncologist at the Dana-Farber Cancer Institute and instructor in medicine at Harvard Medical School
Dana-Farber Cancer Institute
Episode: DLL3 and SEZ6 Expression in Neuroendocrine Carcinomas
Dr. Bryson Katona
Director of the Gastrointestinal Cancer Genetics Program and Director of the Lynch Syndrome Program
Penn Medicine's Abramson Cancer Center
Episode: Areas of Uncertainty in Pancreatic Cancer Surveillance
Dr. Asaf Maoz
Medical oncologist at Dana-Farber Cancer Institute, Brigham and Women's Hospital, and faculty at Harvard Medical School
Dana-Farber Cancer Institute
Episode: Lynch Syndrome Mortality in the Immunotherapy Era

Hosts

Dr. Rafeh Naqash
Podcast Editor for JCO Precision Oncology and associate professor; multiple affiliations noted across episodes; widely featured host
Jiasen He
Host of JCO Precision Oncology Article Insights

Reviews

5.0 out of 5 stars from 8 ratings
  • Great show!

    Fantastic show that helps a busy resident digest important articles from JCO

    Apple Podcasts
    5
    lexigreen361
    United States3 months ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

High-quality discussions that connect research to patient care.
Good for clinicians needing quick, practical takeaways.
Digestible, timely summaries of complex oncology articles.
Strong guest lineup from top cancer centers adds credibility.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

ctDNA in Metastatic Invasive Lobular Carcinoma
Q: What was the research question? What was the patient population?
The research focused on using a tumor-informed assay to determine ctDNA levels in metastatic lobular breast cancer patients and assess the correlation with treatment responses.
ctDNA in Metastatic Invasive Lobular Carcinoma
Q: Could you tell us what it is? What are some of the genomic characteristics?
Invasive lobular carcinoma makes up about 10 to 15 percent of all breast cancers and is characterized by unique growth patterns and lower detection rates in imaging.
Proteomics Predictor for Immunotherapy Benefit
Q: What has being a mentor meant for you?
Being a mentor has been crucial for Dr. Gandara's career, allowing him to give back to the next generation of oncologists and guide them in their development.
Proteomics Predictor for Immunotherapy Benefit
Q: Can you tell us a little bit about the plasma proteomic aspirin?
The plasma proteomic assay was developed to assess plasma proteins in cancer patients and normal individuals, focusing on those with non-small cell lung cancer.
Transcriptome and ctDNA Associates with Pembrolizumab Benefit
Q: How did you choose the genes to include in your analysis?
The genes were selected based on their association with T-cell activation and the immunosuppressive tumor microenvironment.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About JCO Precision Oncology Conversations

What is JCO Precision Oncology Conversations about and what kind of topics does it cover?

A concise overview of cutting-edge oncology discourse that centers on how new genomic, liquid-biopsy, and targeted-therapy research translates into clinical practice. Episodes routinely unpack analytical validation for ctDNA MRD tests, genomic risk classifiers in localized cancers, FGFR2b and FGFR3 targeting, and the evolving role of immunotherapy across multiple tumor types. A notable pattern is the emphasis on practical trial design, biomarker-driven treatment decisions, and real-world applicability of complex research, with guest clinicians and researchers offering clear implications for patient care, trial enrollment, and precision oncology strategy. Distinctive strengths include access to leading cancer centers, rigorous expert analysi... more

Where can I find podcast stats for JCO Precision Oncology Conversations?

Rephonic provides a wide range of podcast stats for JCO Precision Oncology Conversations. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to JCO Precision Oncology Conversations and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does JCO Precision Oncology Conversations get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for JCO Precision Oncology Conversations, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for JCO Precision Oncology Conversations?

Rephonic provides comprehensive predictive audience data for JCO Precision Oncology Conversations, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does JCO Precision Oncology Conversations have?

To see how many followers or subscribers JCO Precision Oncology Conversations has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to JCO Precision Oncology Conversations?

These podcasts share a similar audience with JCO Precision Oncology Conversations:

1. ASCO Daily News
2. Journal of Clinical Oncology (JCO) Podcast
3. ASCO Guidelines
4. Science Friday
5. OncLive® On Air

How many episodes of JCO Precision Oncology Conversations are there?

JCO Precision Oncology Conversations launched 4 years ago and published 68 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact JCO Precision Oncology Conversations?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for JCO Precision Oncology Conversations?

Rephonic pulls ratings and reviews for JCO Precision Oncology Conversations from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for JCO Precision Oncology Conversations?

Rephonic provides full transcripts for episodes of JCO Precision Oncology Conversations. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on JCO Precision Oncology Conversations?

Recent guests on JCO Precision Oncology Conversations include:

1. Dr. Aziza Nassar
2. Dr. Julia Foldi
3. Dr. Rebecca Hassoun
4. Dr. Zao Wainberg
5. Dr. Shilpa Gupta
6. Dr. Jessica Ross
7. Dr. Alissa Cooper
8. Dr. Bryson Katona

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days